Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03505320
Title A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer (ILUSTRO)
Acronym ILUSTRO
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA

Facility Status City State Zip Country Details
University of Chicago Chicago Illinois 60637 United States Details
Mass General / North Shore Can Boston Massachusetts 02114 United States Details
Weill Cornell Medical College New York New York 10065 United States Details
Site FR33003 Pessac Nouvelle-Aquitaine 33604 France Details
Site FR33002 Poitiers Nouvelle-Aquitaine 86021 France Details
Site FR33001 Brest France Details
Site FR33004 Paris 75015 France Details
Site IT39005 Milano Italy Details
Site IT39002 Napoli Italy Details
Site IT39004 Padova Italy Details
Site IT39003 Pisa Italy Details
Site JP81001 Chiba Japan Details
Site JP81002 Tokyo Japan Details
Site JP81003 Tokyo Japan Details
Site KR82002 Seongnam-si Korea, Republic of Details
Site KR82001 Seoul Korea, Republic of Details
Site TW88601 Taichung Taiwan Details
Site TW88602 Tainan 70403 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field